与败血症相关的急性肝损伤中的非编码RNA:作用,机制和治疗应用
Jialian Wang1, Xingyu Tao1, Zhengyang Liu2
1Department of Intensive Care Medicine, Chongqing Emergency Medical Center, Chongqing University Central Hospital, School of Medicine, Chongqing University, Chongqing 400016, China.
Pharmacological research
|January 12, 2025
概括
非编码RNAs (ncRNAs) 在败血症相关的急性肝损伤 (SA-ALI) 中至关重要. 本综述探讨了它们在疾病机制中的作用,以及它们作为SA-ALI的诊断生物标志物和治疗点的潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 关键护理医学 关键护理医学
背景情况:
- 败血症相关的急性肝损伤 (SA-ALI) 是败血症的严重并发症,死亡率高.
- 目前SA-ALI的诊断标志物和治疗方法有限,需要新的方法.
- 非编码RNAs (ncRNAs) 越来越多地被认为参与SA-ALI病变.
研究的目的:
- 审查SA-ALI中各种ncRNAs (miRNAs, lncRNAs, circRNAs) 的关键作用.
- 总结目前关于ncRNAs调节SA-ALI关键病理过程的研究.
- 探索ncRNAs作为SA-ALI的诊断生物标志物和治疗点的潜力.
主要方法:
- 文献综述侧重于ncRNAs在败血症相关的急性肝损伤.
- 对研究微RNA,长非编码RNA和圆形RNA的研究进行分析.
- 高通量测序技术的整合及其对SA-ALI研究的影响.
主要成果:
- 在SA-ALI中,ncRNAs在调节"细胞因子风暴",氧化应激,线粒体功能障碍和编程细胞死亡方面发挥着重要作用.
- 在SA-ALI中对长非编码RNA和循环RNA的现有研究显示出有希望但有限的发现.
- 测序技术的进步为SA-ALI中的ncRNA功能提供了新的见解.
结论:
- ncRNAs代表了开发SA-ALI新型诊断生物标志物和治疗策略的有希望的途径.
- 需要进行进一步的研究,以克服SA-ALI基于ncRNA的临床翻译方法的挑战.
- 了解ncRNA调节网络是改善SA-ALI患者治疗结果的关键.
相关概念视频
Types of RNA
63.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.1K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Riboswitches
8.0K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.0K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Ribozymes
11.2K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
11.2K


